Nikkei Asian Infectious Diseases Conference Renewing Our Commitment to Fight Communicable Diseases
日本語のページはこちら

Jan.16-17 2015 The Second Nikkei Asia Conference is here

Okinawa Communicable Diseases Statement 2014 PDF Download

With the recent outbreaks of highly lethal communicable diseases such as SARS and H1N1, the prevention of such diseases in the Asian region has become one of the top issues for not only the global healthcare but also for the global economy. Communicable diseases are a huge risk factor for economic growth of Asian countries; once a major outbreak occurs in Asia, not only vast loss of lives but also a huge damage to the corporate world and to the economy will be done.

The recent string of outbreaks of diseases such as H1N1 has revealed the fact that there is a critical lack of collaboration in the area of disease prevention.
Under such circumstance, the importance for Japan to play a leading role in fighting against the threat of communicable diseases is ever demanding.

Asian Conference: Renewal of Our Commitment to Fight against Communicable Diseases will gather in one place the pharmaceutical manufacturers, the government officials, academics, public health organizations and all those who relates to the prevention of communicable disease. Its aims will be to function as a base infrastructure of the new and effective network among the stakeholders, and to build social awareness of the importance of immunization. The conference will also provide framework for the proposals of effective measures to the government policy in the area of disease prevention throughout Asia.

Conference Overview

Date
February 14 (Fri) 2014 9:50〜21:20 (Doors open at 9:30)、
February 15 (Sat) 2014 9:00〜12:20 (Doors open at 8:30)
Venue
Okinawa Bankoku Shinryokan
1792 Kise, Nago-shi, Okinawa, 905-0026
TEL: +81-980-53-3155
FAX: +81-980-53-3163
Organizer
Nikkei Inc., Nikkei Business Publications, Inc.
In association with
Okinawa Prefectural Government
Support
Ministry of Health, Labour and Welfare (scheduled), Ministry of Foreign Affairs (scheduled), Ministry of Education, Culture, Sports, Science and Technology
Cosponsors
DAIICHI SANKYO COMPANY, LIMITED、Otsuka Pharmaceutical Co., Ltd.、
TOYAMA CHEMICAL CO., LTD、Kirin Holdings Company,Limited, 、SARAYA CO., LTD、
Sumitomo Chemical Co., Ltd.、Dainippon Sumitomo Pharma Co., Ltd.
Admission
Free admission: Participants will be selected by a draw. Pre-registration for the draw is required. Confirmation of your participation will be sent by email.

Program

* Please note the program, including lecturers and times, is subject to change without notice.

application form was closed.

■February 14 (Fri) 2014

* For afternoon sessions, please select and register your sessions.

9:30

Doors open

9:50〜9:55

Opening Remarks

Ryosuke.Harada
NIKKEI INC.
Managing Exective Officer and General Manager of Global Bussiness Bureau

9:55〜10:00

Guest Speech

Minister for Foreign Affairs
Mr. Hirotaka ISHIHARA

10:00〜10:30

Special Lecture by Mr. Keizo Takemi, Liberal Democratic Party, Member of the House of Councilors

10:30〜11:00

Keynote Speech: "Uncertain Times"

Dr. Kiyoshi Kurokawa, Academic Fellow, National Graduate Institute for Policy Studies
Chairman, Health and Global Policy Institute (HGPI)


11:00〜11:30

Mr.LE QUANG CUONG

Special Speech Minister, Vice Minister of Health of the S.R. Vietnam
Mr.LE QUANG CUONG

11:30〜11:40

Break

11:40〜13:00

[Panel Discussion I]
"Current Status and Problems of Infectious Diseases in the World and Asia: What is Required?" (draft)
Outbreak of H7N9, Tuberculosis, Tropical Diseases, etc.: Current Status and Risks of Infectious Diseases in Asia

<Panelists>

Dr. Nikki Shindo

Dr. Nikki Shindo, Medical Officer, Global Influenza Programme, World Health Organization

Prof. Gabriel M Leung, Dean

Prof. Gabriel M Leung, Dean, Li Ka Shing Faculty of Medicine, The University of Hong Kong

Dr. Supamit Chunsuttiwat

Dr. Supamit Chunsuttiwat, Senior Medical Officer, Preventive Medicine, Department of Disease Control, Ministry of Public Health, Thailand

Dr. Srihadi Agungpriyono

Dr. Srihadi Agungpriyono, DVM, Ph.D Dean, Faculty of Veterinary Medicine, Bogor Agricultural University (IPB)


<Moderator>

Dr. Hitoshi Oshitani

Dr. Hitoshi Oshitani, Professor, Tohoku University Graduate School of Medicine Department of Virology

13:00〜14:00

Lunch Break

14:00〜15:20

[Panel Discussion II]
"What are Japan's Strengths and Weaknesses Concerning Infectious Disease Control?" (draft)
Introduction of Latest Research Technology of Japan and Okinawa Prefecture, e.g. Diagnosis by Genome Analysis, Vaccines, Wide-Spectrum Antiviral Drugs, New Anti-tuberculosis Drugs

<Panelists>

Prof. Kimiyasu Shiraki

Prof. Kimiyasu Shiraki, Director, Clinical Research and Ethics Center, University of Toyama

Dr. Tatsuya Kondo

Dr. Tatsuya Kondo, Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA)

Dr. Tokuaki Shobayashi

Dr. Tokuaki Shobayashi, Director, Tuberculosis and Infectious Diseases Control Division, Health Service Bureau, Ministry of Health, Labour and Welfare

Dr. Yasuhiro Yasutomi

Dr. Yasuhiro Yasutomi
Tsukuba Primate Res. Center・Director, Dept. of Mol. Exp. Med.・Professor
National Institute of Biomedical Innovation
Mie University Graduate School of Medicine

Dr Mercy Ahun

Dr Mercy Ahun
Special Representative for GAVI Eligible Countries.


<Moderator>

Mr. Mitsuru Miyata

Mitsuru Miyata, Executive Leader Writer, Nikkei Business Publications, Inc.

15:20〜15:50

Break

Under adjustment

Under adjustment

15:50〜16:50

A-1 Under adjustment

Presented by Kirin Holdings Company,Limited and Saraya

Dr. Nikki Shindo, Medical Officer, Global Influenza Programme, World Health Organization (WHO)

Mr.Yoshiharu Yoneyama

Mr.Yoshiharu Yoneyama
Deputy Director General, and Group Director for Health 1, Human Development Department
Japan International Cooperation Agency

Dr.Ngoquy Chau

Dr.Ngoquy Chau
Vice director of Bach Mai hospital and director of Respiratory Centesr

Mr.Trannhu Duong

Mr.Trannhu Duong
Deputy Direcor of NIHE

Satoshi Nakagawa, Ph.D.

Satoshi Nakagawa, Ph.D.
General Manager, Scientific Affairs and Research Planning Department KYOWA HAKKO BIO CO., LTD. Healthcare Products Development Center

Takeo Hojo

Takeo Hojo
General manager, International Procurement Planning Sec.,
SCM Div.BOP Business Unit,Global Operations Div,SARAYA Co., Ltd.

<Moderator>

Susumu Namikawa

Susumu Namikawa
Social Designer, Creative Director, Copy Writer Social Design Engine, DENTSU INC.

<サブモデレータ>

Sayaka Watanabe

Sayaka Watanabe
CEO and Founder of re:terra. Director of Tohoku Support, IMPACT Japan.

B-1 Action Plan of Okinawa for the Crisis Infection.

Chair: Dr. Kuniaki Nerome, CEO, The Institute of Biological Resources

Co-chair: Dr. Jiro Fujita, Professor, Dept.of Infectious, Respiratory, and Digestive Medicine, Faculty of Medicine, University of the Ryukyu

【I. Infection surveillance field】
Presented by Okinawa Prefectural Government

Dr. Jiro Fujita, Professor, Dept.of Infectious, Respiratory, and Digestive Medicine, Faculty of Medicine, University of the Ryukyu

Dr. Tomohiko Takasaki

Dr. Tomohiko Takasaki, Chief, Dept of virology 1st, National Institute of Infectious Diseases

【II. Vaccine and development of therapeutic agents】
Presented by Okinawa Prefectural Government

Dr. Kuniaki Nerome, CEO, The Institute of Biological Resources

Dr. Masahiro Tomita

Dr. Masahiro Tomita, Executive Officer, Immuno-Biological Laboratories Co., Ltd.

17:00〜18:00

A-2 The Infection Needs in Asia and Roles that Japan can Play or Should Play

Presented by Daiichi Sankyo

Kazuki Hoshino, Ph.D.

Dr. Kouya Shiba, M.D.,
Guest Professor,
The Jikei University School of Medicine, Professor, Tokyo Healthcare University

Dr. Jiro Fujita, M.D.,
Professor, Dept.of Infectious, Respiratory, and Digestive Medicine, Faculty of Medicine, University of the Ryukyu

Dr. Visanu Thamlikitkul, M.D.,

Dr. Visanu Thamlikitkul, M.D.,
Professor, Department of Medicine,
Siriraj Hospital, Mahidol University, Thailand

Mr. Akira Kawahara
Managing Director
Japan Pharmaceutical Manufacturers Association (JPMA)

Dr. Nikki Shindo,
Medical Officer, Global Influenza Programme, World Health Organization

Mr. Mitsuru Miyata,
Executive Leader Writer, Nikkei Business Publications, Inc.

Masahiko Kikuchi, Ph.D.

Masahiko Kikuchi, Ph.D.
Vice President, Vaccine Business Intelligence Division
Vaccine Business Strategy Department in Daiichi Sankyo Co., Ltd.

Kazuki Hoshino, Ph.D.

Kazuki Hoshino, Ph.D.
Senior Director, Vaccine Research Group, Vaccine Business Strategy Department, Vaccine Business Intelligence Division, Daiichi Sankyo Co., Ltd.

Norihito Ueda, MD, Ph.D.

Norihito Ueda, MD, Ph.D.\
Senior Director, R&D Planning & Implementation Group, Vaccine Business Strategy Department, Vaccine Business Intelligence Division, Daiichi Sankyo Co.,

B-2 The Project of Establishing Medical Research Base Networks Against Infectious Diseases in Okinawa

Yuetsu Tanaka

Yuetsu Tanaka
Professor, Department of Immunology, Graduate School of Medicine, University of the Ryukyus

Takuya Fukushima

Takuya Fukushima
Professor, School of Health Sciences, Faculty of Medicine, University of the Ryukyus

Hisami Watanabe Ph.D.

Hisami Watanabe Ph.D.
Professor, Immunobiology Group, Center of Molecular Biosciences, Tropical Biosphere Research Center and Department of Infection Immunobiology, Graduate School of Medicine, University of the Ryukyus. President of Jectas Innovators Co., Ltd.

Arakawa, Takeshi

Arakawa, Takeshi
Associate Professor, Tropical Biosphere Research Center University of the Ryukyus

Takashi Hirano

Takashi Hirano
Okinawa Institute of Advanced Sciences CTO

Toshihiro Horii

Toshihiro Horii
Professor, Department of Infection Metagenomics, Genome Information Research Center Professor, Department of Molecular Protozoology, Research Center for Infectious Disease Control Director of lntemational Research Center for Infectious Diseases

18:10〜19:10

A-3 New Horizon for Virus Infection Treatment - Anti-Viral Agent with Novel Mechanism of Action -

Presented by Toyama Chemical

<Panelists>

Dr. Osamu Kobayashi

Dr. Osamu Kobayashi, Professor, Kyorin University Faculty of Health Science

Dr. Nikki Shindo, Medical Officer, Global Influenza Programme, World Health Organization (WHO)

Dr. Masato Tashiro, Director, Center for Influenza Virus Research, National Institute of Infectious Diseases

Dr. Jiro Fujita, Professor, Department of Infectious, Respiratory, and Digestive Medicine, Faculty of Medicine, University of the Ryukyus

<Moderator>

Prof. Kimiyasu Shiraki, Director, Clinical Research and Ethics Center, University of Toyama

B-3 Moving Together: Global Challenges in Treating TB and MDR-TB

Presented by Otsuka Pharmaceutical Co., Ltd.、

<Panel Speakers>

Dr. Tadao Shimao,
Adviser, Japan Anti-Tuberculosis Association

Professor Lee Reichman

Professor Lee Reichman, Executive Director, New Jersey Medical School Global Tuberculosis Institute

Dr. Hiroshi Ishikawa

Dr. Hiroshi Ishikawa, Fellow, Otsuka Pharmaceutical

<Moderator>

Mitsuru Miyata, Executive Leader Writer, Nikkei Business Publications, Inc.

19:20〜21:20

Reception

■February 15 (Sat) 2014

8:30

Doors open

9:00〜10:20

[Panel DiscussionIII]
"Based on the Summary of the Sessions: Contribution Expected from Japan Concerning Infectious Disease Control in Asia, and the Role of Okinawa Prefecture, One of the Asian Hubs" (draft)
Redefinition of Japan's Role in Consideration of Japan's Experience and Technology, and "Okinawa Infectious Diseases Initiative" Announced at the Okinawa Summit

<Panelists>

Dr. Jiro Fujita

Dr. Jiro Fujita, Professor, Department of Infectious, Respiratory, and Digestive Medicine, Faculty of Medicine, University of the Ryukyus

Dr. Kuniaki Nerome

Dr. Kuniaki Nerome, CEO, The Institute of Biological Resources

Dr. Kuniaki Nerome

Mr.Akira Kawahara
Managing Director
Japan Pharmaceutical Manufacturers Association (JPMA) 

Dr. Masato Tashiro

Dr. Masato Tashiro, Director, Center for Influenza Virus Research, National Institute of Infectious Diseases


<Moderator>

Dr. Tadao Shimao

Dr. Tadao Shimao,
Adviser, Japan Anti-Tuberculosis Association

10:20〜11:40

【Panel Discussion IV】
"Conclusion: Okinawa Statement 2014" (draft)
Statement from the Conference Based on Panel Discussions I, II & III

<Panelists>

Dr. Hitoshi Oshitani, Professor, Tohoku University Graduate School of Medicine Department of Virology
Dr. Tadao Shimao, Adviser, Japan Anti-Tuberculosis Association
Mr. Mitsuru Miyata, Executive Leader Writer, Nikkei Business Publications, Inc.

Panel discussion moderators

Session moderators


<Moderator (Chairperson)>

Dr. Shigeru Omi

Dr. Shigeru Omi, President, Readjustment of Facilities for insured persons and beneficiaries Organization

<Commentators>

Mr. Hideaki Nakagaki

Mr. Hideaki Nakagaki, Deputy Director-General, Office of Healthcare Policy, Cabinet Secretariat,

Dr. Toshinobu Sato

Dr. Toshinobu Sato, Director-General, Health Service Bureau, Ministry of Health, Labour and Welfare

Dr.Tatsuya Miyazato,
director general of Department of Welfare and Health.Okinawa Prefectural Government

11:40〜12:10

Adoption of the Conference statement

12:10〜12:20

Closing greeting

application form was closed.

<Organizer>

Nikkei Inc.  Nikkei Business Publications, Inc.

<In Association with>

Okinawa Prefectural Government

<Sponsors>

DAIICHI SANKYO COMPANY, LIMITED
Otsuka Pharmaceutical Co., Ltd.
TOYAMA CHEMICAL CO., LTD
Kirin Holdings Company,Limited SARAYA CO., LTD
Sumitomo Chemical Co., Ltd.
Dainippon Sumitomo Pharma Co., Ltd.
Secretariat office for:

the Nikkei Asian Infectious Diseases Conference
PCO Works, Inc.
2F., Kanda Urban Bldg., 2-4-2 Kanda-Tsukasamachi,
Chiyoda-ku, Tokyo 101-0048 JAPAN
E-mail: okinawa2014@pcoworks.jp
Tel: +81-3-3291-3633, Fax: +81-3291-3635